...
首页> 外文期刊>BMC proceedings. >Proceedings of the 4th BEAT-PCD Conference and 5th PCD Training School
【24h】

Proceedings of the 4th BEAT-PCD Conference and 5th PCD Training School

机译:第四届击败PCD会议和第五次PCD培训学院的诉讼程序

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Primary ciliary dyskinesia (PCD) is an inherited ciliopathy leading to chronic suppurative lung disease, chronic rhinosinusitis, middle ear disease, sub-fertility and situs abnormalities. As PCD is rare, it is important that scientists and clinicians foster international collaborations to share expertise in order to provide the best possible diagnostic and management strategies. 'Better Experimental Approaches to Treat Primary Ciliary Dyskinesia' (BEAT-PCD) is a multidisciplinary network funded by EU COST Action (BM1407) to coordinate innovative basic science and clinical research from across the world to drive advances in the field. The fourth and final BEAT-PCD Conference and fifth PCD Training School were held jointly in March 2019 in Poznan, Poland. The varied program of plenaries, workshops, break-out sessions, oral and poster presentations were aimed to enhance the knowledge and skills of delegates, whilst also providing a collaborative platform to exchange ideas. In this final BEAT-PCD conference we were able to build upon programmes developed throughout the lifetime of the COST Action. These proceedings report on the conference, highlighting some of the successes of the BEAT-PCD programme.? The Author(s) 2020.
机译:原发性睫状体障碍症(PCD)是一种遗传性的肺病,导致慢性化脓性肺病,慢性鼻窦炎,中耳病,副肥力和体育异常。由于PCD很少见,重要的是,科学家和临床医生促进国际合作来分享专业知识,以便提供最佳诊断和管理战略。 “治疗小学综合性欲障碍的更好的实验方法(Beat-PCD)是由欧盟成本行动(BM1407)资助的多学科网络,以协调世界各地的创新基础科学和临床研究,以推动该领域的进步。第四次和最终击败PCD会议和第五次PCD培训学校于2019年3月在波兰波兹南共同举行。全体全额,讲习班,爆炸会议,口头和海报演示的各种计划旨在提高代表的知识和技能,同时还提供了交换思想的协作平台。在此最终击败PCD会议中,我们能够在整个成本行动的整个终身方面开发的计划。这些诉讼程序就会议报告,突出了击败PCD计划的一些成功。作者2020年。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号